SCHEDULE OF STOCK OPTION ACTIVITY (Details) - USD ($) |
1 Months Ended | 12 Months Ended | ||
|---|---|---|---|---|
Nov. 30, 2023 |
Oct. 31, 2023 |
Dec. 31, 2024 |
Dec. 31, 2023 |
|
| Share-Based Payment Arrangement [Abstract] | ||||
| Number of shares, Unvested | 1,326,982 | |||
| Weighted Average Grant Date Fair Value - Unvested | $ 0.57 | |||
| Weighted average remaining contractual life | 3 months | 3 years 5 months 26 days | ||
| Aggregate intrinsic value | $ 7,998,367 | |||
| Number of shares, Granted | 2,278,108 | 2,278,108 | ||
| Weighted Average Grant Date Fair Value - Granted | ||||
| Number of shares, Vested | (361,303) | |||
| Weighted Average Grant Date Fair Value - Vested | $ 0.57 | |||
| Number of shares, Forfeited | (255,687) | |||
| Weighted Average Grant Date Fair Value - Forfeited | $ 0.60 | |||
| Number of shares, Unvested | 709,992 | 1,326,982 | ||
| Weighted Average Grant Date Fair Value - Unvested | $ 0.56 | $ 0.57 | ||
| Weighted average remaining contractual life | 2 years 6 months 29 days | |||
| Aggregate intrinsic value | $ 2,537,156 | $ 7,998,367 | ||
| X | ||||||||||
- Definition Share based compensation arrangement by share based payment award options vested. No definition available.
|
| X | ||||||||||
- Definition Share based compensation arrangements vested. No definition available.
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition Weighted average remaining contractual term for equity-based awards excluding options, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Gross number of share options (or share units) granted during the period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Number of options outstanding, including both vested and non-vested options. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Weighted average price at which grantees could have acquired the underlying shares with respect to stock options that were terminated. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|